A study of donepezil in female breast cancer survivors with self-reported cognitive dysfunction 1 to 5 years following adjuvant chemotherapy

PURPOSE: Some breast cancer survivors report cognitive difficulties greater than 1 year after chemotherapy. Acetylcholinesterase inhibitors (AChEI) may improve cognitive impairment. We conducted a randomized, placebo-controlled, pilot study to assess the feasibility of using the AChEI, donepezil, to...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Cancer Surviv
Hlavní autoři: Lawrence, J. A., Griffin, L., Balcueva, E. P., Groteluschen, D. L., Samuel, T. A., Lesser, G. J., Naughton, M. J., Case, L. D., Shaw, E. G., Rapp, S. R.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2015
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4930878/
https://ncbi.nlm.nih.gov/pubmed/26130292
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11764-015-0463-x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky